Influence of persistent contaminants and steroid hormones on glioblastoma cell growth

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 70, Issue 1, 2007, Pages 19-27

  Merritt, Rebecca L ^a,b   Foran, Christy M ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b FAIRMONT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CHLORPHENOTANE; DICHLORODIPHENYLDICHLOROETHYLENE; ENVIRONMENTAL CHEMICAL; INDUSTRIAL CHEMICAL; ORGANOCHLORINE PESTICIDE; PERFLUORO COMPOUND; PERFLUORODECANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOATE AMMONIUM; POLYCHLORINATED BIPHENYL; PRASTERONE; STEROID HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CELL COUNT; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; TUMOR GROWTH;

BRAIN NEOPLASMS; ENVIRONMENTAL POLLUTANTS; GLIOBLASTOMA; GONADAL STEROID HORMONES; HUMANS; RECEPTORS, ANDROGEN; TUMOR CELLS, CULTURED;

EID: 33845908712     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390600748807     Document Type: Article

References (48)

1. Aldape, K. D., Okcu, M. F., Bondy, M. L., and Wrensch, M. 2003. Molecular epidemiology of glioblastoma. Cancer J. 9:99-106.
2. Alexander, B. H., Olsen, G. W., Burris, J. M., Mandel, J. H., and Mandel, J. S. 2003. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup. Environ. Med. 60:722-729.
3. Austin, M. E., Kasturi, B. S., Barber, M., Kannan, K., MohanKumar, P. S., and MohanKumar, S. M. 2003. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ. Health Perspect. 111:1485-1489.
4. Bursztajn, S., Feng, J. J., Nanda, A., and Berman, S. A. 2001. Differential responses of human neuroblastoma and glioblastoma to apoptosis. Brain Res. Mol. Brain Res. 91:57-72.
5. Chang, K. H., Chen, M. L., Chen, H. C., Huang, Y. W., Wu, T. Y., and Chen, Y. J. 1999. Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma 46:196-200.
6. Charlier C., Desaive, C., and Plomteux, G. 2002. Human exposure to endocrine disruptors: Consequences of gastroplasty on plasma concentration of toxic pollutants. Int. J. Obes. Relat. Metab. Disord. 26:1465-1468.
7. Dewailly, E., Mulvad, G., Pedersen, S., Ayotte, P., Demers, A., Weber, J., and Hansen J. 1999. Concentration of organochlorines in human brain, liver, and adipose tissue: Autopsy samples from Greenland. Environ. Health Perspect. 107:823-828.
8. Dinglasan, M. A. J., Ye, Y., Edwards, E. A., and Mabury, S. A. 2004. Fluorotelomer alcohol biodegradation yields poly- and perfluorinated acids. Environ. Sci. Technol. 38:2857-2864.
9. Ellis, D. A., Martin, J. W., De Silva, A. O., Mabury, S. A., Hurley, M. D., Sulbaek Andersen, M. P., and Wallington, T. J. 2004. Degradation of fluorotelomer alcohols: A likely atmospheric source of perfluorinated carboxylic acids. Environ. Sci. Technol. 38:3316-3321.
10. Fujikawa, D. G., Itabashi, H. H., Wu, A., and Shinmei, S. S. 2000. Status of epilepticus-induced neuronal loss in humans without systemic complications of epilepsy. Epilepsia 41:981-991.
11. Garman, R. H., Snellings, W. V., and Maronpot, R. R. 1986. Frequency, size and location of brain tumours in F-344 rats chronically exposed to ethylene oxide. Food Chem. Toxicol. 24:145-153.
12. Giesy, J. P., and Kannan, K. 2002. Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 36:147A-152A.
13. Gilliland, F. D., and Mandel, J. S. 1993. Mortality among employees of a perfluorooctanoic acid production plant. J. Occup. Med. 35:950-954.
14. Hopewell, J. W. 1970. The effects of castration on the induction of experimental gliomas in male rats. Br. J. Cancer 24:187-190.
15. Huang, C., Hu, S., and Chen, B. 2001. Growth inhibition of epidermal growth factor-stimulated human glioblastoma cells by nicardipine in vitro. J. Neurosurg. Sci. 45:151-155.
16. Ishimaru, H., Morikawa, M., Iwanaga, S., Kaminogo, M., Ochi, M., and Hayashi, K. 2001. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur. Radiol. 11:1784-1791.
17. Kaaks, R., Lukanova, A., and Sommersberg, B. 2000. Plasma androgens, IGF-1, body size, and prostate cancer risk: A synthetic review. Prostate Cancer Prostatic Dis. 3:157-172.
18. Kannan, K., Corsolini, S., Falandysz, J., Fillman, G., Kumar, K. S., Loganathan, B. G., Ali Mohd, M., Olivero, J., Van Wouwe, N., Yang, J. H., and Aldous, K. M. 2004. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 38:4489-4495.
19. Kudo, N., Bandai, N., Suzuki, E., Katakura, M., and Kawashima, Y. 2000. Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats. Chem. Biol. Interact. 124:119-132.
20. Lee, S. K., Kim, H. J., Kim, J. W., and Lee, J. W. 1999. Steroid receptor coactivation-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. Mol. Endocrinol. 13:1924-1933.
21. Leslie, K. K., Keefe, D., Powell, S., and Naftolin, F. 1994. Estrogen receptors are identified in the glioblastoma cell line U138MG. J. Soc. Gynecol. Invest. 1:238-244.
22. Liu, X. H., Wiley, H. S., and Meikle, A. W. 1993. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor. J. Clin. Endocrinol. Metab. 77:1472-1478.
23. Lordo, R. A., Dinh, K. T., and Schwemberger, J. G. 1996. Semivolatile organic compounds in adipose tissue: estimated averages for the US population and selected subpopulations. Am. J. Public Health 86:1253-1259.
24. Lorimer, I. A., and Lavictoire, S. J. 2000. Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe. J. Immunol. Methods 237:147-157.
25. Lowe, S., Bodis, S., McClatchy, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810.
26. McKinley, B. P., Michalek, A. M., Fenstermaker, R. A., and Plunkett, R. J. 2000. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J. Neurosurg. 93:932-939.
27. Miyaji, K., Tani, E., Shindo, H., Nakano, A., and Tokunaga, T. 1994. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas. J. Neurosug. 81:411-419.
28. Morocz, I. A., Schmitter, D., Lauber, B., and Stahel, R. A. 1994. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway. Br. J. Cancer 70:850-856.
29. Murdoch, W. J., and Van Kirk, E. A. 2002. Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells. Mol. Cell. Endocrinol. 186:61-67.
30. Muscat, J. E., Britton, J. A., Djordjevic, M. V., Citron, M. L., Kemeny, M., Busch-Devereaux, E., Pittman, B., and Stellman, S. D. 2003. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol. Biomarkers Prev. 12:1474-1478.
31. Ogiichi, T., Hirashima, Y., Nakamura, S., Endo, S., Kurimoto, M., and Takaku, A. 2000. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. J. Neurooncol. 46:1-9.
32. Ohno, H. 2000. Effects of testosterone on cell proliferation and apoptosis in BBN-induced mouse bladder carcinogenesis. Yonago Acta Med 43:121-130.
33. Olsen, C. T., and Andersen, M. E. 1983. The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmacol. 70:362-372.
34. Olsen, G. W., Church, T. R., Miller, J. P., Burris, J. M., Hansen, K. J., Lundberg, J. K., Armitage, J. B., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., O'Neill, E. M., Mandel, J. H., and Zobel, L. R. 2004. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111:1892-1901.
35. Payne, J., Scholze, M., and Kortenkamp, A. 2001. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ. Health Perspect. 109:391-397.
36. Plunkett, R., Agneiszka, L., and Barone, T. 1999. Hormonal effects on glioblastoma multiforme in the nude rat model. J. Neurosurg. 90:1072-1077.
37. Pollack, I. F., Erff, M., and Ashkenazi, A. 2001. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin. Cancer Res. 7:1362-1369.
38. Ralph, J. L., Orgebin-Crist, M. C., Lareyre, J. J., and Nelson, C. C. 2003. Disruption of androgen regulation in the prostate by the environmental contaminant hexachlorobenzene. Environ. Health Perspect. 111:461-466.
39. Ron, E., Modan, B., Boice, J. D., Jr., Alfandry, E., Stovall, M., Chetrit, A., and Katz, L. 1988. Tumors of the brain and central nervous system after radiotherapy in childhood. N. Engl. J. Med. 319:1033-1039.
40. Ryu, J., Pyo, H., Jou, I., and Joe, E. 2000. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J. Biol. Chem. 275:29955-29959.
41. Steinmetz, R., Young, P. C., Caperell-Grant, A., Gize, E. A., Madhukar, B. V., Ben-Jonathan, N., and Bigsby, R. M. 1996. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res. 56:5403-5409.
42. Takahashi, J. A., Fukumoto, M., Kozai, Y., Ito, N., Oda, Y., Kikuchi, H., and Hatanaka, M. 1991. Inhibition of cell growth and tumorigenesis of human glioblastoma cells by neutralizing antibody against human basic fibroblast growth factor. FEBS Lett. 288:65-71.
43. Vanden Heuvel, J. P., Davis, J. W. II, Sommers, R., and Peterson, R. E. 1992. Renal excretion of perfluorooctanoic acid in male rats: inhibitory effect of testosterone. J. Biochem. Toxicol. 7:31-36.
44. von Schoultz, E., Bixo, M., Backstrom, T., Silfvenius, H., Wilking, N., and Henriksson, R. 1990. Sex steroids in human brain tumors and breast cancer. Cancer 65:949-952.
45. Ylinen, M., and Auriola, S. 1990. Tissue distribution and elimination of perfluorodecanoic acid in the rat after single intraperitoneal administration. Pharmacol. Toxicol. 66:45-48.
46. Ylinen, M., Hanhijarvi, H., Jaakonaho, J., and Peura, P. 1989. Stimulation by oestradiol of the urinary excretion or perfluorooctanoic acid in the male rats. Pharmacol. Toxicol. 65:274-277.
47. Zhang, X. D., Gillespie, S. K., and Hersey, P. 2004. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol. Cancer Ther. 3:187-197.
48. Zulch, K. J. 1986. Brain tumors. Their biology and pathology, 3rd ed. New York: Springer